Oncolytic immunotherapy startup BeneVir gets $3M
BeneVir's cancer vaccines are engineered to incite an immune response, as well as hide from the immune system - so as to have a prolonged anti-cancer effect.
BeneVir's cancer vaccines are engineered to incite an immune response, as well as hide from the immune system - so as to have a prolonged anti-cancer effect.
New York-based biotech company, Cynvec, is currently raising capital to aid in the development of a vaccine designed to treat ovarian cancer.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The most damning insight comes from the question of why they stopped using the apps they downloaded.
The project is funded in part by an effort of the American Medical Association to update what and how medical students are taught. Students can use tools provided by the project to look at quality measures for things like heart failure, diabetes, smoking, etc.
When you hear someone scream, a very specific part of your brain gets activated.
Johnson & Johnson will create a bioethics panel to evaluate when unapproved drugs still in testing phase should be made available to patients who are terminally ill.
For Travis Hill, it was an offer too good to refuse. Last year when the 30-year-old neuroscientist was admitted to a new program at New York University that would allow him to complete medical school in only three years and guarantee him a spot in its neurosurgery residency, he seized it. Not only would Hill […]
A biotech accelerator launched as part of a $250 million drug discovery initiative spearheaded by Cleveland’s University Hospitals has spun off its first company to develop promising technology for treating inflammatory diseases. Orca Pharmaceuticals is the first company announced by BioMotiv, the for-profit accelerator associated with the Harrington Discovery Project at UH. BioMotiv in- licenses […]